60+
Molecular laboratories supported across Nigeria.
DemyHealth has advanced from a bold care-access vision into a trusted platform for molecular diagnostics, DNA testing, and precision medicine support across Nigeria.
Impact Highlights
60+
Molecular laboratories supported across Nigeria.
2M+
Molecular tests, consumables, and research kits supported.
Since 2018
Extensive physician-led DNA, forensic, and relationship testing ecosystem.
A flyer-inspired timeline flow showing how DemyHealth scaled laboratory infrastructure, closed testing gaps, and expanded molecular diagnostics capabilities.
Chapter 1
Access
2010β2012 foundations in physician-led care access.
Chapter 2
Build
2016β2019 expansion of molecular laboratory capacity.
Chapter 3
Lead
Early 2020 to today, sustained diagnostics leadership.
2010
DemyHealth began as a physician-led concierge medical service to bridge healthcare access gaps and improve patient-centered care during long delays and fragmented systems.
2012
The mission expanded into a physician-led diagnostic and molecular laboratory platform focused on faster, evidence-based clinical decision support.
2016β2017
DemyHealth established its first in-house molecular laboratory while supporting third-party molecular laboratory implementation projects.
2018
The organization expanded extensively into DNA, forensic, and extended relationship testing with strict chain-of-custody, confidentiality, and scientific reliability standards.
2019
Multiple molecular laboratory setups were completed across Nigeria, accelerating access to advanced molecular testing infrastructure.
Early 2020
A major molecular laboratory expansion was completed before COVID-19, positioning DemyHealth to support high-demand molecular diagnostics.
Today
DemyHealth continues evolving as a healthcare, biotechnology, genomics, and precision medicine platform improving outcomes across Africa.
Flyer-Inspired Visual Panel
60+ molecular laboratories supported through setup, process optimization, and diagnostics enablement.
Automated DNA extraction capability milestones integrated to improve throughput and quality consistency.
Hepatitis C genotype testing gap bridged to support more complete clinical decision pathways.
Sustained physician-led molecular diagnostics leadership across healthcare and laboratory ecosystems.
Visual Storyboard
A concise snapshot of DemyHealth milestones, branch growth, and molecular diagnostics contributions across Nigeria.
2010
Care access mission begins
2016β2020
Molecular capacity acceleration
Today
Precision diagnostics leadership